Page last updated: 2024-08-23

raloxifene hydrochloride and Coronary Artery Disease

raloxifene hydrochloride has been researched along with Coronary Artery Disease in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (20.00)18.2507
2000's8 (80.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abramson, BL; Amewou-Atisso, M; Barrett-Connor, E; Collins, P; Dowsett, SA; Geiger, MJ; Grady, D; Kornitzer, M; Mosca, L; Paganini-Hill, A; Wenger, N1
Jneid, H; Shepard, DR; Thacker, HL1
Celermajer, DS; Griffiths, KA; Harmer, JA; Sader, MA; Skilton, MR1
Flevari, P; Koniavitou, K; Kremastinos, DT; Kroupis, C; Kyriakides, ZS; Sbarouni, E1
Pines, A1
Levo, Y; Pines, A1
Anthony, MS; Clarkson, TB; Jerome, CP1
Bryant, HU; Cox, DA; Heath, H; Iversen, P; Kauffman, RF; Mitlak, BH1
Clarkson, TB; Mikkola, TS1
Gambacciani, M; Genazzani, AR1

Reviews

3 review(s) available for raloxifene hydrochloride and Coronary Artery Disease

ArticleYear
Gender, hyperlipidemia, and coronary artery disease.
    Comprehensive therapy, 2003,Spring, Volume: 29, Issue:1

    Topics: Adult; Aged; Cardiotonic Agents; Coronary Artery Disease; Estrogen Replacement Therapy; Female; Health Behavior; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Life Style; Male; Middle Aged; Primary Prevention; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators; Sex Factors

2003
Estrogen replacement therapy, atherosclerosis, and vascular function.
    Cardiovascular research, 2002, Feb-15, Volume: 53, Issue:3

    Topics: Aged; Aging; Animals; Coronary Artery Disease; Endothelium, Vascular; Estrogen Replacement Therapy; Estrogens, Non-Steroidal; Female; Humans; Inflammation; Isoflavones; Lipids; Macaca; Male; Middle Aged; Models, Animal; Phytoestrogens; Plant Preparations; Progestins; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators

2002
Controversial issues in climacteric medicine I. Cardiovascular disease and hormone replacement therapy. International Menopause Society Expert Workshop. 13-16 October 2000, royal society of medicine, London, UK.
    Climacteric : the journal of the International Menopause Society, 2000, Volume: 3, Issue:4

    Topics: Coronary Artery Disease; Female; Hormone Replacement Therapy; Humans; Postmenopause; Raloxifene Hydrochloride

2000

Trials

3 trial(s) available for raloxifene hydrochloride and Coronary Artery Disease

ArticleYear
Effect of raloxifene on stroke and venous thromboembolism according to subgroups in postmenopausal women at increased risk of coronary heart disease.
    Stroke, 2009, Volume: 40, Issue:1

    Topics: Comorbidity; Coronary Artery Disease; Humans; Incidence; Middle Aged; Mortality; Postmenopause; Raloxifene Hydrochloride; Risk Assessment; Risk Factors; Selective Estrogen Receptor Modulators; Smoking; Stroke; Treatment Outcome; Venous Thromboembolism

2009
Effects of raloxifene on endothelium-dependent dilation, lipoproteins, and markers of vascular function in postmenopausal women with coronary artery disease.
    Journal of the American College of Cardiology, 2003, Aug-20, Volume: 42, Issue:4

    Topics: Aged; Biomarkers; Coronary Artery Disease; Coronary Vessels; Cross-Over Studies; Double-Blind Method; Endothelin-1; Endothelium, Vascular; Female; Fibrinogen; Humans; Lipoproteins; Middle Aged; Postmenopause; Prospective Studies; Prostaglandins; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Vasodilation

2003
The effects of raloxifene and simvastatin on plasma lipids and endothelium.
    Cardiovascular drugs and therapy, 2003, Volume: 17, Issue:4

    Topics: Aged; Cell Adhesion Molecules; Coronary Artery Disease; Cross-Over Studies; Double-Blind Method; Endothelium, Vascular; Female; Forearm; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipids; Middle Aged; Postmenopause; Raloxifene Hydrochloride; Regional Blood Flow; Selective Estrogen Receptor Modulators; Simvastatin; Vascular Resistance

2003

Other Studies

4 other study(ies) available for raloxifene hydrochloride and Coronary Artery Disease

ArticleYear
Lessons from RUTH.
    Climacteric : the journal of the International Menopause Society, 2006, Volume: 9, Issue:5

    Topics: Breast Neoplasms; Coronary Artery Disease; Female; Humans; Postmenopause; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators; Spinal Fractures; Thromboembolism

2006
Why is the RUTH trial so important?
    Maturitas, 2007, Feb-20, Volume: 56, Issue:2

    Topics: Aged; Aged, 80 and over; Clinical Trials as Topic; Coronary Artery Disease; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride

2007
Lack of effect of raloxifene on coronary artery atherosclerosis of postmenopausal monkeys.
    The Journal of clinical endocrinology and metabolism, 1998, Volume: 83, Issue:3

    Topics: Animals; Coronary Artery Disease; Coronary Vessels; Diet, Atherogenic; Estradiol; Estrogens; Female; Horses; Lipids; Lipoproteins; Macaca fascicularis; Osmolar Concentration; Ovariectomy; Piperidines; Postmenopause; Raloxifene Hydrochloride

1998
Comment on lack of effect of raloxifene on coronary artery atherosclerosis of postmenopausal monkeys.
    The Journal of clinical endocrinology and metabolism, 1998, Volume: 83, Issue:8

    Topics: Animals; Coronary Artery Disease; Estrogen Antagonists; Female; Macaca fascicularis; Piperidines; Postmenopause; Raloxifene Hydrochloride

1998